• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向心力衰竭中心肌细胞细胞周期调控。

Targeting cardiomyocyte cell cycle regulation in heart failure.

机构信息

Department of Medicine III, Cardiology/Angiology/Nephrology, Goethe University Hospital, 60590, Frankfurt am Main, Germany.

Institute for Cardiovascular Regeneration, Goethe University, 60590, Frankfurt am Main, Germany.

出版信息

Basic Res Cardiol. 2024 Jun;119(3):349-369. doi: 10.1007/s00395-024-01049-x. Epub 2024 Apr 29.

DOI:10.1007/s00395-024-01049-x
PMID:38683371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11142990/
Abstract

Heart failure continues to be a significant global health concern, causing substantial morbidity and mortality. The limited ability of the adult heart to regenerate has posed challenges in finding effective treatments for cardiac pathologies. While various medications and surgical interventions have been used to improve cardiac function, they are not able to address the extensive loss of functioning cardiomyocytes that occurs during cardiac injury. As a result, there is growing interest in understanding how the cell cycle is regulated and exploring the potential for stimulating cardiomyocyte proliferation as a means of promoting heart regeneration. This review aims to provide an overview of current knowledge on cell cycle regulation and mechanisms underlying cardiomyocyte proliferation in cases of heart failure, while also highlighting established and novel therapeutic strategies targeting this area for treatment purposes.

摘要

心力衰竭仍然是一个重大的全球健康问题,导致了大量的发病率和死亡率。成人心脏的再生能力有限,这给寻找心脏病变的有效治疗方法带来了挑战。虽然已经使用了各种药物和手术干预来改善心脏功能,但它们无法解决心脏损伤时发生的大量功能失调的心肌细胞的损失。因此,人们越来越关注了解细胞周期是如何调节的,并探索刺激心肌细胞增殖以促进心脏再生的潜力。本综述旨在概述心力衰竭中心肌细胞增殖的细胞周期调控和机制的现有知识,同时强调针对该领域的既定和新型治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dd/11142990/64c620ebc8cb/395_2024_1049_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dd/11142990/64c620ebc8cb/395_2024_1049_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7dd/11142990/64c620ebc8cb/395_2024_1049_Fig1_HTML.jpg

相似文献

1
Targeting cardiomyocyte cell cycle regulation in heart failure.靶向心力衰竭中心肌细胞细胞周期调控。
Basic Res Cardiol. 2024 Jun;119(3):349-369. doi: 10.1007/s00395-024-01049-x. Epub 2024 Apr 29.
2
Induced Cardiomyocyte Proliferation: A Promising Approach to Cure Heart Failure.诱导心肌细胞增殖:治疗心力衰竭的有前途方法。
Int J Mol Sci. 2021 Jul 19;22(14):7720. doi: 10.3390/ijms22147720.
3
Stimulating Cardiogenesis as a Treatment for Heart Failure.刺激心脏生成术治疗心力衰竭。
Circ Res. 2019 May 24;124(11):1647-1657. doi: 10.1161/CIRCRESAHA.118.313573.
4
Long Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair.长链非编码 RNA CPR(心肌细胞增殖调节剂)调节心肌细胞增殖和心脏修复。
Circulation. 2019 Jun 4;139(23):2668-2684. doi: 10.1161/CIRCULATIONAHA.118.035832. Epub 2019 Mar 5.
5
Control of p21Cip by BRCA1-associated protein is critical for cardiomyocyte cell cycle progression and survival.BRCA1 相关蛋白对 p21Cip 的控制对于心肌细胞周期进程和存活至关重要。
Cardiovasc Res. 2020 Mar 1;116(3):592-604. doi: 10.1093/cvr/cvz177.
6
Cardiomyocyte Proliferation for Therapeutic Regeneration.心肌细胞增殖治疗再生。
Curr Cardiol Rep. 2018 Jun 14;20(8):63. doi: 10.1007/s11886-018-1011-x.
7
Cardiomyocyte maturation and its reversal during cardiac regeneration.心肌细胞成熟及其在心脏再生过程中的逆转。
Dev Dyn. 2024 Jan;253(1):8-27. doi: 10.1002/dvdy.557. Epub 2022 Dec 21.
8
Therapeutic opportunities for cell cycle re-entry and cardiac regeneration.细胞周期重新进入与心脏再生的治疗机会。
Cardiovasc Res. 2004 Dec 1;64(3):395-401. doi: 10.1016/j.cardiores.2004.09.003.
9
Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.Hippo 信号缺失导致压力超负荷时心肌细胞去分化伴随的心脏功能障碍。
Circ Res. 2019 Jan 18;124(2):292-305. doi: 10.1161/CIRCRESAHA.118.314048.
10
Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration.调控心肌细胞命运可塑性:心脏再生的关键策略。
Signal Transduct Target Ther. 2021 Jan 27;6(1):31. doi: 10.1038/s41392-020-00413-2.

引用本文的文献

1
Peripheral blood mesenchymal stem cell-derived exosomes improve renal sympathetic denervation efficacy through β-catenin-mediated cardiac reprogramming.外周血间充质干细胞来源的外泌体通过β-连环蛋白介导的心脏重编程提高肾交感神经去神经支配疗效。
Clin Transl Med. 2025 Sep;15(9):e70475. doi: 10.1002/ctm2.70475.
2
Sirt4 Deficiency Promotes Cardiomyocyte Proliferation and Cardiac Repair.沉默调节蛋白4缺乏促进心肌细胞增殖和心脏修复。
J Cell Mol Med. 2025 Aug;29(16):e70741. doi: 10.1111/jcmm.70741.
3
Anti-senescence therapies: a new concept to address cardiovascular disease.

本文引用的文献

1
Response by Tang et al to Letter Regarding Article, "Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy".唐等人对关于“Jmjd4促进心肌细胞中Pkm2降解并对扩张型心肌病具有保护作用”一文的信件的回复
Circulation. 2023 Dec 12;148(24):1980-1981. doi: 10.1161/CIRCULATIONAHA.123.066937. Epub 2023 Dec 11.
2
Inhibition of fatty acid oxidation enables heart regeneration in adult mice.脂肪酸氧化抑制可促进成年小鼠的心脏再生。
Nature. 2023 Oct;622(7983):619-626. doi: 10.1038/s41586-023-06585-5. Epub 2023 Sep 27.
3
CCND2 Modified mRNA Activates Cell Cycle of Cardiomyocytes in Hearts With Myocardial Infarction in Mice and Pigs.
抗衰老疗法:应对心血管疾病的新概念。
Cardiovasc Res. 2025 May 23;121(5):730-747. doi: 10.1093/cvr/cvaf030.
4
Identification of novel biomarkers, shared molecular signatures and immune cell infiltration in heart and kidney failure by transcriptomics.通过转录组学鉴定心脏和肾脏衰竭中的新型生物标志物、共享分子特征和免疫细胞浸润。
Front Immunol. 2024 Sep 16;15:1456083. doi: 10.3389/fimmu.2024.1456083. eCollection 2024.
CCND2 修饰 mRNA 激活心肌梗死后小鼠和猪心脏中的心肌细胞周期。
Circ Res. 2023 Sep;133(6):484-504. doi: 10.1161/CIRCRESAHA.123.322929. Epub 2023 Aug 11.
4
Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction.衰老的心肌细胞会导致心肌梗死后的心脏功能障碍。
NPJ Aging. 2023 Jun 14;9(1):15. doi: 10.1038/s41514-023-00113-5.
5
TMEM11 regulates cardiomyocyte proliferation and cardiac repair via METTL1-mediated mG methylation of ATF5 mRNA.TMEM11 通过 METTL1 介导的 ATF5 mRNA 的 mG 甲基化调节心肌细胞增殖和心脏修复。
Cell Death Differ. 2023 Jul;30(7):1786-1798. doi: 10.1038/s41418-023-01179-0. Epub 2023 Jun 7.
6
Polycomb Group Protein CBX7 Represses Cardiomyocyte Proliferation Through Modulation of the TARDBP/RBM38 Axis.多梳蛋白 CBX7 通过调节 TARDBP/RBM38 轴抑制心肌细胞增殖。
Circulation. 2023 Jun 13;147(24):1823-1842. doi: 10.1161/CIRCULATIONAHA.122.061131. Epub 2023 May 9.
7
Btg1 and Btg2 regulate neonatal cardiomyocyte cell cycle arrest.Btg1 和 Btg2 调节新生儿心肌细胞细胞周期阻滞。
J Mol Cell Cardiol. 2023 Jun;179:30-41. doi: 10.1016/j.yjmcc.2023.03.016. Epub 2023 Apr 14.
8
Regulation of endogenous cardiomyocyte proliferation: The known unknowns.内源性心肌细胞增殖的调控:已知的未知。
J Mol Cell Cardiol. 2023 Jun;179:80-89. doi: 10.1016/j.yjmcc.2023.04.001. Epub 2023 Apr 6.
9
Cardiomyocyte ploidy is dynamic during postnatal development and varies across genetic backgrounds.心肌细胞的倍性在出生后发育过程中是动态变化的,并因遗传背景而异。
Development. 2023 Apr 1;150(7). doi: 10.1242/dev.201318. Epub 2023 Apr 13.
10
Systemic Hypoxemia Induces Cardiomyocyte Hypertrophy and Right Ventricular Specific Induction of Proliferation.系统性低氧血症诱导心肌细胞肥大和右心室特异性增殖。
Circ Res. 2023 Mar 17;132(6):723-740. doi: 10.1161/CIRCRESAHA.122.321604. Epub 2023 Feb 17.